{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:42:52Z","timestamp":1784641372369,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Tumor induced osteomalacia (TIO) is a rare disease of mineral metabolism, whose clinical picture is dominated by hypophosphatemia usually due to an excess of circulating FGF23 produced by small mesenchymal tumors. Data on the real prevalence of the disease are lacking, with the knowledge of the disease mainly relying on case reports and small case series. No estimate is available on the prevalence of uncured TIO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>National multi-center, cross-sectional and retrospective study on persistent or recurrent cases of TIO followed in referral centers for bone diseases<jats:bold>;<\/jats:bold> systematic review of the published persistent and recurrent cases of TIO. Data from patients consecutively evaluated in referral Italian centers for bone diseases were collected; a PubMed search on persistent, recurrent and unoperable cases of TIO was carried out.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixteen patients (mean age at diagnosis 52.5\u2009\u00b1\u200910.6 years) with persistent (<jats:italic>n<\/jats:italic>\u2009=\u20096, 37,5%), recurrent (<jats:italic>n<\/jats:italic>\u2009=\u20097, 43.7%) or not operable (<jats:italic>n<\/jats:italic>\u2009=\u20093, 18.8%) TIO were described. Delay in diagnosis (2.5\u2009\u00b1\u20091.3 years) was demonstrated. All patients experienced fragility fractures or pseudofractures and disabling bone and muscle pain. BMD was significantly reduced (mean T-score \u22122.7\u2009\u00b1\u20091.7 and \u22122.7\u2009\u00b1\u20090.9 at lumbar spine and femoral neck, respectively). Fourteen patients were maintained under therapy with phosphate salts and calcitriol, while in 2 patients therapy with burosumab, an anti-FGF23 antibody, was commenced.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A significant number of patients with TIO remain either undiagnosed for tumor localization or tumor recur or persist after surgery. These patients with active disease represent possible candidates for burosumab treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-022-03039-2","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:19:06Z","timestamp":1649186346000},"page":"709-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey\/case series"],"prefix":"10.1007","volume":"76","author":[{"given":"Luisella","family":"Cianferotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Delli Poggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Caffarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gonnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mazzantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viapiana","family":"Ombretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Setti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Varenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"issue":"1","key":"3039_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"A.L. Folpe, J.C. Fanburg-Smith, S.D. Billings, M. Bisceglia, F. Bertoni, J.Y. Cho et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 28(1), 1\u201330 (2004). https:\/\/doi.org\/10.1097\/00000478-200401000-00001","journal-title":"Am J Surg Pathol."},{"issue":"10","key":"3039_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","volume":"41","author":"JM Boland","year":"2018","unstructured":"J.M. Boland, P.J. Tebben, A.L. Folpe, Phosphaturic mesenchymal tumors: What an endocrinologist should know. J Endocrinol Invest. 41(10), 1173\u201384 (2018). https:\/\/doi.org\/10.1007\/s40618-018-0849-5","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"3039_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"P. Florenzano, I.R. Hartley, M. Jimenez, K. Roszko, R.I. Gafni, M.T. Collins, Tumor-induced Osteomalacia. Calcif Tissue Int. 108(1), 128\u201342 (2021). https:\/\/doi.org\/10.1007\/s00223-020-00691-6","journal-title":"Calcif Tissue Int."},{"issue":"9","key":"3039_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","volume":"62","author":"I Endo","year":"2015","unstructured":"I. Endo, S. Fukumoto, K. Ozono, N. Namba, D. Inoue, R. Okazaki et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J. 62(9), 811\u20136 (2015). https:\/\/doi.org\/10.1507\/endocrj.EJ15-0275","journal-title":"Endocr J."},{"issue":"1","key":"3039_CR5","first-page":"33","volume":"16","author":"RA McCANCE","year":"1947","unstructured":"R.A. McCANCE, Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med. 16(1), 33\u201346 (1947)","journal-title":"Q J Med."},{"key":"3039_CR6","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"A. Prader, R. Illig, E. Uehlinger, G. Stalder, [Rickets following bone tumor]. Helvetica Paediatrica Acta. 14, 554\u201365 (1959)","journal-title":"Helvetica Paediatrica Acta."},{"issue":"3","key":"3039_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002560050581","volume":"29","author":"M Sundaram M","year":"2000","unstructured":"M. Sundaram M, E.F. McCarthy, Oncogenic osteomalacia. Skelet Radio. 29(3), 117\u201324 (2000). https:\/\/doi.org\/10.1007\/s002560050581","journal-title":"Skelet Radio."},{"key":"3039_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","volume":"7","author":"P Florenzano","year":"2017","unstructured":"P. Florenzano, R.I. Gafni, M.T. Collins, Tumor-induced osteomalacia. Bone Rep. 7, 90\u20137 (2017). https:\/\/doi.org\/10.1016\/j.bonr.2017.09.002","journal-title":"Bone Rep."},{"key":"3039_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/bonekey.2013.231","volume":"3","author":"S Fukumoto","year":"2014","unstructured":"S. Fukumoto, Phosphate metabolism and vitamin D. BoneKEy Rep. 3, 497 (2014). https:\/\/doi.org\/10.1038\/bonekey.2013.231","journal-title":"BoneKEy Rep."},{"key":"3039_CR10","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"S. Minisola, M. Peacock, S. Fukumoto, C. Cipriani, J. Pepe, S.H. Tella et al. Tumour-induced osteomalacia. Nat Rev Di Prim. 3, 17044 (2017). https:\/\/doi.org\/10.1038\/nrdp.2017.44","journal-title":"Nat Rev Di Prim."},{"issue":"11","key":"3039_CR11","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00198-018-4618-2","volume":"29","author":"G Marcucci","year":"2018","unstructured":"G. Marcucci, L. Masi, S. Ferrari, D. Haffner, M.K. Javaid, P. Kamenick\u00fd et al. Phosphate wasting disorders in adults. Osteoporos Int. 29(11), 2369\u201387 (2018). https:\/\/doi.org\/10.1007\/s00198-018-4618-2","journal-title":"Osteoporos Int."},{"issue":"1","key":"3039_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0221-8747(81)80020-3","volume":"3","author":"PJ Marie","year":"1981","unstructured":"P.J. Marie, F.H. Glorieux, Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Relat Res. 3(1), 31\u20138 (1981). https:\/\/doi.org\/10.1016\/s0221-8747(81)80020-3","journal-title":"Metab Bone Dis Relat Res."},{"issue":"7","key":"3039_CR13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s00198-017-4007-2","volume":"28","author":"G Gonz\u00e1lez","year":"2017","unstructured":"G. Gonz\u00e1lez, R. Baudrand, M.F. Sep\u00falveda, N. Vucetich, F.J. Guarda, P. Villanueva et al. Tumor-induced osteomalacia: Experience from a South American academic center. Osteoporos Int. 28(7), 2187\u201393 (2017). https:\/\/doi.org\/10.1007\/s00198-017-4007-2","journal-title":"Osteoporos Int."},{"issue":"6","key":"3039_CR14","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"W.H. Chong, P. Andreopoulou, C.C. Chen, J. Reynolds, L. Guthrie, M. Kelly et al. Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res. 28(6), 1386\u201398 (2013). https:\/\/doi.org\/10.1002\/jbmr.1881","journal-title":"J Bone Miner Res."},{"issue":"6","key":"3039_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11926-015-0512-5","volume":"17","author":"AH Hautmann","year":"2015","unstructured":"A.H. Hautmann, M.G. Hautmann, O. K\u00f6lbl, W. Herr, W.M. Fleck, Tumor-induced osteomalacia: An up-to-date review. Curr Rheumatol Rep. 17(6), 512 (2015). https:\/\/doi.org\/10.1007\/s11926-015-0512-5","journal-title":"Curr Rheumatol Rep."},{"issue":"3","key":"3039_CR16","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"W.H. Chong, A.A. Molinolo, C.C. Chen, M.T. Collins, Tumor-induced osteomalacia. Endocr Relat Cancer 18(3), R53\u2013R77 (2011). https:\/\/doi.org\/10.1530\/ERC-11-0006","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"3039_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF03343720","volume":"23","author":"QL Huang","year":"2000","unstructured":"Q.L. Huang, D.S. Feig, M.E. Blackstein, Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia. J Endocrinol Invest. 23(4), 263\u20137 (2000). https:\/\/doi.org\/10.1007\/BF03343720","journal-title":"J Endocrinol Invest."},{"issue":"8","key":"3039_CR18","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.3162","volume":"32","author":"D Ovejero","year":"2017","unstructured":"D. Ovejero, D. El-Maouche, B.A. Brillante, A. Khosravi, R.I. Gafni, M.T. Collins, Octreotide is ineffective in treating tumor-induced osteomalacia: Results of a short-term therapy. J Bone Miner Res. 32(8), 1667\u201371 (2017). https:\/\/doi.org\/10.1002\/jbmr.3162","journal-title":"J Bone Miner Res."},{"issue":"10189","key":"3039_CR19","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"E.A. Imel, F.H. Glorieux, M.P. Whyte, C.F. Munns, L.M. Ward, O. Nilsson et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 393(10189), 2416\u201327 (2019). https:\/\/doi.org\/10.1016\/S0140-6736(19)30654-3","journal-title":"Lancet."},{"issue":"8","key":"3039_CR20","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"K.L. Insogna, K. Briot, E.A. Imel, P. Kamenick\u00fd, M.D. Ruppe, A.A. Portale et al. AXLES 1 investigators. A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an Anti-FGF23 antibody, in adults with X-Linked hypophosphatemia: Week 24 primary analysis. J Bone Miner Res. 33(8), 1383\u201393 (2018). https:\/\/doi.org\/10.1002\/jbmr.3475","journal-title":"J Bone Miner Res."},{"issue":"5","key":"3039_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","volume":"105","author":"AA Portale","year":"2019","unstructured":"A.A. Portale, T.O. Carpenter, M.L. Brandi, K. Briot, H.I. Cheong, M. Cohen-Solal et al. Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: Results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period. Calcif Tissue Int. 105(5), 271\u201384 (2019). https:\/\/doi.org\/10.1007\/s00223-019-00568-3","journal-title":"Calcif Tissue Int."},{"issue":"8","key":"3039_CR22","doi-asserted-by":"publisher","first-page":"e10190","DOI":"10.1002\/jbm4.10190","volume":"3","author":"EA Imel","year":"2019","unstructured":"E.A. Imel, A. Biggin, A. Schindeler, C.F. Munns, FGF23, hypophosphatemia, and emerging treatments. J Bone Miner Res. 3(8), e10190 (2019). https:\/\/doi.org\/10.1002\/jbm4.10190","journal-title":"J Bone Miner Res."},{"issue":"2","key":"3039_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jbmr.4184","volume":"36","author":"Y Imanishi","year":"2021","unstructured":"Y. Imanishi, N. Ito, Y. Rhee, Y. Takeuchi, C.S. Shin, Y. Takahashi et al. Fukumoto. interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia. J Bone Miner Res. 36(2), 262\u201370 (2021). https:\/\/doi.org\/10.1002\/jbmr.4184","journal-title":"J Bone Miner Res."},{"issue":"4","key":"3039_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jbmr.4233","volume":"36","author":"SM Jan de Beur","year":"2021","unstructured":"S.M. Jan de Beur, P.D. Miller, T.J. Weber, M. Peacock, K. Insogna, R. Kumar et al. Burosumab for the treatment of tumor-induced osteomalacia. J Bone Miner Res. 36(4), 627\u201335 (2021). https:\/\/doi.org\/10.1002\/jbmr.4233","journal-title":"J Bone Miner Res."},{"issue":"10","key":"3039_CR25","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1530\/EC-19-0341","volume":"8","author":"R Shah","year":"2019","unstructured":"R. Shah, A.R. Lila, R.S. Jadhav, V. Patil, A. Mahajan, S. Sonawane et al. Tumor induced osteomalacia in head and neck region: Single center experience and systematic review. Endocr Connect. 8(10), 1330\u201353 (2019). https:\/\/doi.org\/10.1530\/EC-19-0341","journal-title":"Endocr Connect."},{"issue":"3","key":"3039_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1530\/EC-18-0552","volume":"8","author":"R Pal","year":"2019","unstructured":"R. Pal, S.K. Bhadada, A. Singhare, A. Bhansali, S. Kamalanathan, M. Chadha et al. Tumor-induced osteomalacia: experience from three tertiary care centers in India. Endocr. Connect. 8(3), 266\u201376 (2019). https:\/\/doi.org\/10.1530\/EC-18-0552","journal-title":"Endocr. Connect."},{"issue":"1","key":"3039_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1756-1","volume":"18","author":"Q-Y Zuo","year":"2017","unstructured":"Q.-Y. Zuo, H. Wang, W. Li, X.-H. Niu, Y.-H. Huang, J. Chen et al. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. BMC Musculoskelet Disord. 18(1), 403 (2017). https:\/\/doi.org\/10.1186\/s12891-017-1756-1","journal-title":"BMC Musculoskelet Disord."},{"issue":"1","key":"3039_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/24699322.2017.1282044","volume":"22","author":"H Kobayashi","year":"2017","unstructured":"H. Kobayashi, T. Akiyama, T. Okuma, Y. Shinoda, H. Oka, N. Ito et al. Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones. Comput Assist Surg. 22(1), 14\u20139 (2017). https:\/\/doi.org\/10.1080\/24699322.2017.1282044","journal-title":"Comput Assist Surg."},{"issue":"13","key":"3039_CR29","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","volume":"97","author":"H Wang","year":"2015","unstructured":"H. Wang, D. Zhong, Y. Liu, Y. Jiang, G. Qiu, X. Weng et al. Surgical treatments of tumor-induced osteomalacia lesions in long bones: Seventeen cases with more than one year of follow-up. J Bone Jt Surg Am. 97(13), 1084\u201394 (2015). https:\/\/doi.org\/10.2106\/JBJS.N.01299","journal-title":"J Bone Jt Surg Am."},{"issue":"11","key":"3039_CR30","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","volume":"471","author":"CK Ledford","year":"2013","unstructured":"C.K. Ledford, N.A. Zelenski, D.M. Cardona, B.E. Brigman, W.C. Eward, The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed? Clin Orthop Relat Res. 471(11), 3618\u201325 (2013). https:\/\/doi.org\/10.1007\/s11999-013-3178-1","journal-title":"Clin Orthop Relat Res."},{"issue":"9","key":"3039_CR31","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Y. Jiang, W. Xia, X. Xing, B.C. Silva, M. Li, O. Wang et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res. 27(9), 1967\u201375 (2012). https:\/\/doi.org\/10.1002\/jbmr.1642","journal-title":"J Bone Miner Res."},{"issue":"8","key":"3039_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/RLU.0b013e318279eb13","volume":"38","author":"N Naswa","year":"2013","unstructured":"N. Naswa, P. Sharma, R. Kumar, A. Malhotra, C. Bal, Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET\/CT. Clin Nucl Med. 38(8), 639\u201340 (2013). https:\/\/doi.org\/10.1097\/RLU.0b013e318279eb13","journal-title":"Clin Nucl Med."},{"issue":"1","key":"3039_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000307468","volume":"3","author":"KB Peters","year":"2010","unstructured":"K.B. Peters, R. McLendon, M.A. Morse, J.J. Vredenburgh, Treatment of recurrent intracranial hemangiopericytoma with SRC-related tyrosine kinase targeted therapy: A case report. Case Rep Oncol. 3(1), 93\u20137 (2010). https:\/\/doi.org\/10.1159\/000307468","journal-title":"Case Rep Oncol."},{"issue":"12","key":"3039_CR34","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/rheumatology\/39.12.1415","volume":"39","author":"GP Clunie","year":"2000","unstructured":"G.P. Clunie, P.E. Fox, T.C. Stamp, Four cases of acquired hypophosphataemic (\u2019oncogenic\u2019) osteomalacia. Probl. diagnosis, Treat long-term Manag Rheumatol (Oxf.) 39(12), 1415\u201321 (2000). https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1415","journal-title":"Probl. diagnosis, Treat long-term Manag Rheumatol (Oxf.)"},{"issue":"4","key":"3039_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3171\/2012.12.JNS12598","volume":"118","author":"DA Mathis","year":"2013","unstructured":"D.A. Mathis, E.J. Stehel, J.E. Beshay, B.E. Mickey, A.L. Folpe, J. Raisanen, Intracranial phosphaturic mesenchymal tumors: Report of 2 cases. J Neurosurg. 118(4), 903\u20137 (2013). https:\/\/doi.org\/10.3171\/2012.12.JNS12598","journal-title":"J Neurosurg."},{"issue":"1","key":"3039_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2169\/internalmedicine1962.21.35","volume":"21","author":"G Nomura","year":"1982","unstructured":"G. Nomura, Y. Koshino, H. Morimoto, H. Kida, S. Nomura, K. Tamai, Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case. Jpn J Med. 21(1), 35\u20139 (1982). https:\/\/doi.org\/10.2169\/internalmedicine1962.21.35","journal-title":"Jpn J Med."},{"issue":"8","key":"3039_CR37","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00296-011-2018-4","volume":"32","author":"W Xian-Ling","year":"2012","unstructured":"W. Xian-Ling, B. Jian-Ming, Z. Wen-Wen, L. Zhao-Hui, D. Jing-Tao, L. Ju-Ming et al. Osteomalacia caused by tumors in facies cranii mimicking rheumatoid arthritis. Rheumatol Int. 32(8), 2573\u20136 (2012). https:\/\/doi.org\/10.1007\/s00296-011-2018-4","journal-title":"Rheumatol Int."},{"issue":"2","key":"3039_CR38","first-page":"45","volume":"8","author":"G Guglielmi","year":"2011","unstructured":"G. Guglielmi, M. Bisceglia, A. Scillitani, A.L. Folpe, Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses. Clin Cases Miner Bone Metab. 8(2), 45\u20139 (2011)","journal-title":"Clin Cases Miner Bone Metab."},{"issue":"17","key":"3039_CR39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMcpc1104567","volume":"365","author":"C Bergwitz","year":"2011","unstructured":"C. Bergwitz, M.T. Collins, A.E. R.S. Kamath, Rosenberg. Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia. N Engl J Med. 365(17), 1625\u201335 (2011). https:\/\/doi.org\/10.1056\/NEJMcpc1104567","journal-title":"N Engl J Med."},{"issue":"2","key":"3039_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41379-018-0100-0","volume":"32","author":"H Wu","year":"2019","unstructured":"H. Wu, M.M. Bui, L. Zhou, D. Li, H. Zhang, D. Zhong, Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review. Mod Pathol. 32(2), 189\u2013204 (2019). https:\/\/doi.org\/10.1038\/s41379-018-0100-0","journal-title":"Mod Pathol."},{"issue":"2","key":"3039_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4158\/EP.11.2.108","volume":"11","author":"MB Zimering","year":"2005","unstructured":"M.B. Zimering, F.A. Caldarella, K.E. White, M.J. Econs, Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes. Endocr Pract. 11(2), 108\u201314 (2005). https:\/\/doi.org\/10.4158\/EP.11.2.108","journal-title":"Endocr Pract."},{"issue":"6","key":"3039_CR42","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1210\/js.2016-1088","volume":"1","author":"A Nair","year":"2017","unstructured":"A. Nair, S. Chakraborty, P. Dharmshaktu, N. Tandon, Y. Gupta, R. Khadgawat et al. Peptide receptor radionuclide and octreotide: A novel approach for metastatic tumor-induced osteomalacia. J Endocr Soc. 1(6), 726\u201330 (2017). https:\/\/doi.org\/10.1210\/js.2016-1088","journal-title":"J Endocr Soc."},{"issue":"3","key":"3039_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jbmr.3903","volume":"35","author":"X Li","year":"2019","unstructured":"X. Li, Y. Jiang, L. Huo, H. Wu, Y. Liu, J. Jin et al. Nonremission and recurrent tumor-induced osteomalacia: A retrospective study. J Bone Miner Res. 35(3), 469\u201377 (2019). https:\/\/doi.org\/10.1002\/jbmr.3903","journal-title":"J Bone Miner Res."},{"issue":"4","key":"3039_CR44","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.4158\/EP13042.CR","volume":"19","author":"S Yasuda","year":"2013","unstructured":"S. Yasuda, S. Wada, S. Kono, T. Miyajima, H. Oda, S. Katayama et al. Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutions. Endocr Pract. 19(4), e97\u2013e101 (2013). https:\/\/doi.org\/10.4158\/EP13042.CR","journal-title":"Endocr Pract."},{"issue":"4","key":"3039_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2967\/jnmt.116.177873","volume":"44","author":"S Basu","year":"2016","unstructured":"S. Basu, P. Fargose, 177Lu-DOTATATE PRRT in recurrent skull-base phosphaturic mesenchymal tumor causing osteomalacia: A potential application of PRRT beyond neuroendocrine tumors. J Nucl Med Technol. 44(4), 248\u201350 (2016). https:\/\/doi.org\/10.2967\/jnmt.116.177873","journal-title":"J Nucl Med Technol."},{"issue":"2","key":"3039_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3342\/ceo.2014.7.2.145","volume":"7","author":"GG Lee","year":"2014","unstructured":"G.G. Lee, H.-J. Dhong, Y.-S. Park, Y.H. Ko, Sinonasal glomangiopericytoma causing oncogenic osteomalacia. Clin Exp Otorhinolaryngol. 7(2), 145\u20138 (2014). https:\/\/doi.org\/10.3342\/ceo.2014.7.2.145","journal-title":"Clin Exp Otorhinolaryngol."},{"key":"3039_CR47","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/1097-0142(19850415)55:8<1691::AID-CNCR2820550814>3.0.CO;2-S","volume":"55","author":"N Weidner","year":"1985","unstructured":"N. Weidner, R.S. Bar, D. Weiss, M.P. Strottmann, Neoplastic pathology of oncogenic osteomalacia\/rickets. Cancer 55, 1691\u2013705 (1985). 10.1002\/1097-0142(19850415)55:8<1691::aid-cncr2820550814>3.0.co;2-s","journal-title":"Cancer"},{"issue":"6","key":"3039_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.rhu.0000101906.15276.ed","volume":"9","author":"C Fuentealba","year":"2003","unstructured":"C. Fuentealba, D. Pinto, F. Ballesteros, D. Pacheco, O. Boettiger, N. Soto et al. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. J Clin Rheumatol. 9(6), 373\u20139 (2003). https:\/\/doi.org\/10.1097\/01.rhu.0000101906.15276.ed","journal-title":"J Clin Rheumatol."},{"issue":"6","key":"3039_CR49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.tripleo.2009.07.005","volume":"108","author":"VL Woo","year":"2009","unstructured":"V.L. Woo, R. Landesberg, E.A. Imel, S.R. Singer, A.L. Folpe, M.J. Econs et al. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature. Oral Surg. Oral Med, Oral Pathol, Oral Radiol Endodontology 108(6), 925\u201332 (2009). https:\/\/doi.org\/10.1016\/j.tripleo.2009.07.005","journal-title":"Oral Surg. Oral Med, Oral Pathol, Oral Radiol Endodontology"},{"key":"3039_CR50","doi-asserted-by":"publisher","unstructured":"H.-C. Schober, C. Kneitz, F. Fieber, K. Hesse, H. Schroeder. Selective blood sampling for FGF-23 in tumor-induced osteomalacia. Endocrinol. Diabetes Metab. Case Rep. 2017 17-0006 (2017) https:\/\/doi.org\/10.1530\/EDM-17-0006","DOI":"10.1530\/EDM-17-0006"},{"issue":"10","key":"3039_CR51","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1507\/endocrj.EJ17-0177","volume":"64","author":"T Hana","year":"2017","unstructured":"T. Hana, S. Tanaka, H. Nakatomi, M. Shojima, S. Fukumoto, M. Ikemura et al. Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23. Endocr J. 64(10), 1033\u20139 (2017). https:\/\/doi.org\/10.1507\/endocrj.EJ17-0177","journal-title":"Endocr J."},{"issue":"52","key":"3039_CR52","doi-asserted-by":"publisher","first-page":"e13849","DOI":"10.1097\/MD.0000000000013849","volume":"97","author":"J Li","year":"2018","unstructured":"J. Li, Y. Huang, F. Yang, Q. Zhang, D. Chen, Q. Wang, Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report. Med. (Baltim.) 97(52), e13849 (2018). https:\/\/doi.org\/10.1097\/MD.0000000000013849","journal-title":"Med. (Baltim.)"},{"issue":"5","key":"3039_CR53","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/0194599820904055","volume":"162","author":"R Tang","year":"2020","unstructured":"R. Tang, S. Mao, H. Lin, H.-B. Ye, D.-W. Li, Z.-N. Chen et al. Surgical treatment and outcomes for sinonasal and skull base phosphaturic mesenchymal tumors. Otolaryngol Head Neck Surg. 162(5), 674\u201382 (2020). https:\/\/doi.org\/10.1177\/0194599820904055","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"4","key":"3039_CR54","doi-asserted-by":"publisher","first-page":"e18603","DOI":"10.1097\/MD.0000000000018603","volume":"99","author":"S Liu","year":"2020","unstructured":"S. Liu, X. Zhou, A. Song, Z. Huo, Y. Wang, Y. Liu, Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report. Med. (Baltim.) 99(4), e18603 (2020). https:\/\/doi.org\/10.1097\/MD.0000000000018603","journal-title":"Med. (Baltim.)"},{"issue":"1","key":"3039_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/wjnm.WJNM_92_18","volume":"19","author":"MI Bhalla","year":"2020","unstructured":"M.I. Bhalla, K.M. Wirtz, E.S. Fair, D.J. Bucklan, 68Ga-DOTATATE positron emission tomography\/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia. World J Nucl Med. 19(1), 78\u201381 (2020). https:\/\/doi.org\/10.4103\/wjnm.WJNM_92_18","journal-title":"World J Nucl Med."},{"issue":"11","key":"3039_CR56","doi-asserted-by":"publisher","first-page":"e14846","DOI":"10.1097\/MD.0000000000014846","volume":"98","author":"Y Li","year":"2019","unstructured":"Y. Li, Y. Li, M. Hui, Y. Liu, X. Liu, J. Jin et al. Comparison of surgical treatments of tumor-induced osteomalacia in different locations in the lower limbs: A retrospective study. Med. (Baltim.) 98(11), e14846 (2019). https:\/\/doi.org\/10.1097\/MD.0000000000014846","journal-title":"Med. (Baltim.)"},{"issue":"10","key":"3039_CR57","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","volume":"41","author":"A Agaimy","year":"2017","unstructured":"A. Agaimy, M. Michal, S. Chiosea, F. Petersson, L. Hadravsky, G. Kristiansen et al. Phosphaturic mesenchymal tumors: Clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol. 41(10), 1371\u201380 (2017). https:\/\/doi.org\/10.1097\/PAS.0000000000000890","journal-title":"Am J Surg Pathol."},{"issue":"17","key":"3039_CR58","doi-asserted-by":"publisher","first-page":"e6750","DOI":"10.1097\/MD.0000000000006750","volume":"96","author":"S Qiu","year":"2017","unstructured":"S. Qiu, L.-L. Cao, Y. Qiu, P. Yan, Z.-X. Li, J. Du et al. Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report. Med. (Baltim.) 96(17), e6750 (2017). https:\/\/doi.org\/10.1097\/MD.0000000000006750","journal-title":"Med. (Baltim.)"},{"issue":"2","key":"3039_CR59","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12105-015-0668-3","volume":"10","author":"H Qari","year":"2016","unstructured":"H. Qari, A. Hamao-Sakamoto, C. Fuselier, Y.-S.L. Cheng, H. Kessler, J. Wright, Phosphaturic mesenchymal tumor: 2 new oral cases and review of 53 cases in the head and neck. Head Neck Pathol. 10(2), 192\u2013200 (2016). https:\/\/doi.org\/10.1007\/s12105-015-0668-3","journal-title":"Head Neck Pathol."},{"key":"3039_CR60","doi-asserted-by":"publisher","first-page":"150025","DOI":"10.1530\/EDM-15-0025","volume":"2015","author":"MP Yavropoulou","year":"2015","unstructured":"M.P. Yavropoulou, N. Gerothanasi, A. Frydas, E. Triantafyllou, C. Poulios, P. Hytiroglou et al. Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors. Endocrinol Diabetes Metab Case Rep. 2015, 150025 (2015). https:\/\/doi.org\/10.1530\/EDM-15-0025","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"issue":"964","key":"3039_CR61","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1259\/bjr\/58168443","volume":"81","author":"SC Chua","year":"2008","unstructured":"S.C. Chua, S.R. O\u2019Connor, W.L. Wong, R.H. Ganatra, Case report: Solitary plasmacytoma of bone with oncogenic osteomalacia: Recurrence of tumour confirmed by PET\/CT. A case report with a review of the radiological literature. Br J Radio. 81(964), e110\u2013e14 (2008). https:\/\/doi.org\/10.1259\/bjr\/58168443","journal-title":"Br J Radio."},{"issue":"1","key":"3039_CR62","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","volume":"36","author":"N Uramoto","year":"2009","unstructured":"N. Uramoto, M. Furukawa, T. Yoshizaki, Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue. Auris Nasus Larynx 36(1), 104\u20135 (2009). https:\/\/doi.org\/10.1016\/j.anl.2008.01.003","journal-title":"Auris Nasus Larynx"},{"issue":"20","key":"3039_CR63","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2169\/internalmedicine.45.1797","volume":"45","author":"K Yoshioka","year":"2006","unstructured":"K. Yoshioka, R. Nagata, M. Ueda, T. Yamaguchi, Y. Konishi, M. Hosoi et al. Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy. Intern Med. 45(20), 1157\u201360 (2006). https:\/\/doi.org\/10.2169\/internalmedicine.45.1797","journal-title":"Intern Med."},{"issue":"2","key":"3039_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002560000306","volume":"30","author":"A Ogose","year":"2001","unstructured":"A. Ogose, T. Hotta, I. Emura, H. Hatano, Y. Inoue, H. Umezu et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skelet Radiol. 30(2), 99\u2013103 (2001). https:\/\/doi.org\/10.1007\/s002560000306","journal-title":"Skelet Radiol."},{"issue":"2","key":"3039_CR65","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3171\/jns.1996.84.2.0288","volume":"84","author":"K David","year":"1996","unstructured":"K. David, T. Revesz, G. Kratimenos, T. Krausz, H.A. Crockard, Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case Report. J Neurosurg. 84(2), 288\u201392 (1996). https:\/\/doi.org\/10.3171\/jns.1996.84.2.0288","journal-title":"Case Report. J Neurosurg."},{"issue":"9","key":"3039_CR66","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/RLU.0000000000002205","volume":"43","author":"J Ding","year":"2018","unstructured":"J. Ding, L. Wang, S. Zhang, F. Li, L. Huo, Recurrent\/Residual intracranial phosphaturic mesenchymal tumor revealed on 68Ga-DOTATATE PET\/CT. Clin Nucl Med. 43(9), 674\u20135 (2018). https:\/\/doi.org\/10.1097\/RLU.0000000000002205","journal-title":"Clin Nucl Med."},{"key":"3039_CR67","doi-asserted-by":"publisher","unstructured":"F. Allevi, D. Rabbiosi, M. Mandal\u00e0, G. Colletti, Mesenchymal phosphaturic tumour: early detection of recurrence. BMJ Case Rep. 2014, bcr2013202827 (20114) https:\/\/doi.org\/10.1136\/bcr-2013-202827","DOI":"10.1136\/bcr-2013-202827"},{"issue":"4","key":"3039_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.anndiagpath.2012.06.005","volume":"17","author":"HA Fatani","year":"2013","unstructured":"H.A. Fatani, M. Sunbuli, S.Y. Lai, D. Bell, Phosphaturic mesenchymal tumor: A report of 6 patients treated at a single institution and comparison with reported series. Ann Diagn Pathol. 17(4), 319\u201321 (2013). https:\/\/doi.org\/10.1016\/j.anndiagpath.2012.06.005","journal-title":"Ann Diagn Pathol."},{"key":"3039_CR69","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00256-015-2246-x","volume":"44","author":"M Higley","year":"2015","unstructured":"M. Higley, B. Beckett, S. Schmahmann, E. Dacey, E. Foss, Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia. Skelet Radiol. 44, 1825\u201331 (2015). https:\/\/doi.org\/10.1007\/s00256-015-2246-x","journal-title":"Skelet Radiol."},{"issue":"4","key":"3039_CR70","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0002-9343(85)90411-5","volume":"78","author":"RG Firth","year":"1985","unstructured":"R.G. Firth, C.S. Grant, B.L. Riggs, Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases. Am J Med. 78(4), 669\u201373 (1985). https:\/\/doi.org\/10.1016\/0002-9343(85)90411-5","journal-title":"Am J Med."},{"issue":"4","key":"3039_CR71","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2265.1992.tb02342.x","volume":"37","author":"JN Harvey","year":"1992","unstructured":"J.N. Harvey, C. Gray, P.E. Belchetz, Oncogenous osteomalacia and malignancy. Clin Endocrinol. (Oxf.) 37(4), 379\u201382 (1992). https:\/\/doi.org\/10.1111\/j.1365-2265.1992.tb02342.x","journal-title":"Clin Endocrinol. (Oxf.)"},{"issue":"1","key":"3039_CR72","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jbspin.2019.07.012","volume":"87","author":"AL Day","year":"2020","unstructured":"A.L. Day, O.M. Guti\u00e9rrez, B.L. Guthrie, K.G. Saag, Burosumab in tumor-induced osteomalacia: A case report. Jt. Bone Spine 87(1), 81\u20133 (2020). https:\/\/doi.org\/10.1016\/j.jbspin.2019.07.012","journal-title":"Jt. Bone Spine"},{"issue":"4","key":"3039_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00223-009-9275-1","volume":"85","author":"D Rendina","year":"2009","unstructured":"D. Rendina, G. De Filippo, L. Tauchmanov\u00e0, L. Insabato, R. Muscariello, F. Gianfrancesco et al. Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: A longitudinal study of five cases. Calcif Tissue Int. 85(4), 293\u2013300 (2009). https:\/\/doi.org\/10.1007\/s00223-009-9275-1","journal-title":"Calcif Tissue Int."},{"issue":"6","key":"3039_CR74","doi-asserted-by":"publisher","first-page":"e1518","DOI":"10.1542\/peds.2014-2218","volume":"135","author":"E Fern\u00e1ndez-Cooke","year":"2015","unstructured":"E. Fern\u00e1ndez-Cooke, J. Cruz-Rojo, C. Gallego, A.I. Romance, R. Mosqueda-Pe\u00f1a, Y. Almaden et al. Tumor-induced rickets in a child with a central giant cell granuloma: A case report. Pediatrics 2015 135(6), e1518\u2013e23 (2015). https:\/\/doi.org\/10.1542\/peds.2014-2218","journal-title":"Pediatrics 2015"},{"key":"3039_CR75","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3349\/ymj.2017.58.5.981","volume":"58","author":"JY Lee","year":"2017","unstructured":"J.Y. Lee, H.S. Park, S. Han, J.K. Lim, N. Hong, S.I. Park et al. Localization of oncogenic osteomalacia by systemic venous sampling of fibroblast growth factor 23. Yonsei Med J. 58, 981\u20137 (2017). https:\/\/doi.org\/10.3349\/ymj.2017.58.5.981","journal-title":"Yonsei Med J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03039-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T17:18:01Z","timestamp":1658337481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3039"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03039-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"9 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This is an observational study. The Research Ethics Committee of the University of Florence has confirmed that no ethical approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}